Estradiol-dependent uterine leiomyomas in transgenic mice

Journal of Clinical Investigation

Volumn 98, Issue 3, 1996, Pages 777-784

  Romagnolo, Béatrice ^a   Molina, Thierry ^b   Leroy, Guillaume ^a   Blin, Claudine ^c   Porteux, Arlette ^a   Thomasset, Monique ^c   Vandewalle, Alain ^d   Kahn, Axel ^a   Perret, Christine ^a  

^a INSTITUT COCHIN   (France)

^b HÔTEL DIEU   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d INSERM   (France)

Author keywords

Calbindin D9K; estrogens; SV40 T antigen; tumor; uterine smooth muscle

Indexed keywords

CALBINDIN; ESTRADIOL; ESTROGEN; VIRUS LARGE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; ESTROGEN RELEASE; FEMALE; GENE EXPRESSION; HORMONE RESPONSIVE ELEMENT; MOLECULAR CLONING; MOUSE; MYOMETRIUM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIMIAN VIRUS 40; TRANSGENIC MOUSE; TUMOR LOCALIZATION; UTERUS MYOMA;

EID: 0029968002     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118850     Document Type: Article

References (39)

1. Rein, M.S., and R.A. Novack. 1992. Biology of uterine myomas and myometrium in vitro. Semin. Reprod. Endocrinol. 10:310-319.
2. Hashimoto, K., C. Azuma, T. Kamiura, T. Nobunaga, T. Kanai, M. Sawada, S. Noguchi, and F. Saji. 1995. Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol. Obstet. Invest. 40:204-208.
3. Barbieri, L.R., and J. Andersen. 1992. Uterine leiomyomas: the somatic mutation theory. Sem. Reprod. Endocrinol. 10:301-309.
4. Fields, K.J., J.W. Griffith, and C.M. Lang. 1984. Spontaneous reproductive tract leiomyomas in aged guinea-pigs. J. Comp. Pathol. 101:287-294.
5. Everitt, J.I., D.C. Wolf, S.R. Howe, T.L. Goldsworthy, and C. Walker. 1995. Rodent model of reproductive tract leiomyomata. Clinical and pathological features. Am. J. Pathol. 146:1556-1567.
6. Hanahan, D. 1989. Transgenic mice as probes into complex systems. Science (Wash. DC). 246:1265-1275.
7. Adams, J.M., and S. Cory. 1991. Transgenic models of tumor development. Science (Wash. DC). 254:1161-1167.
8. Fowlis, D., and A. Balmain. 1993. Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia. Eur. J. Cancer. 29A:638-645.
9. Andrews, A.C., M.A. Van der Valk, C.A. Schonenberger, F. Flückiger, M. LeMeur, P. Gerlinger, and B. Groner. 1988. Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice. Genes Dev. 2:1486-1495.
10. Sinn, E., W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder. 1987. Co-expression of MMTV/c-myc genes in transgenic mice. Synergistic action of oncogenes in vivo. Cell. 49:465-475.
11. Tsukamoto, A.S., R. Grosscheld, R.C. Guzman, T. Parslow, and H. Varmus. 1988. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell. 55:619-625.
12. Matsui, Y., S.A. Halter, J.T. Holt, B.L.M. Hogan, and R.J. Coffey. 1990. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell. 61:1147-1155.
13. Perret, C., N. Lomri, N. Gouhier, C. Auffray, and M. Thomasset. 1988. The rat vitamin D-dependent calcium-binding protein (9KDa CaBP) gene. Complete nucleotide sequence and structural organization. Eur. J. Biochem. 172:43-51.
14. Thomasset, M., C.O. Parkes, and P. Cuisinier-Gleizes. 1982. Rat calcium binding proteins: distribution, development and vitamin D dependence. Am. J. Physiol. 6:E483-E488.
15. Perret, C., C. Desplan, and M. Thomasset. 1985. Cholecalcin (a 9-KDa cholecalciferol-induced calcium-binding protein) messenger RNA. Distribution and induction by calcitriol in the rat digestive tract. Eur. J. Biochem. 150:211-217.
16. Warembourg, M., C. Perret, and M. Thomasset. 1986. Distribution of vitamin D-dependent calcium-binding protein messenger ribonucleic acid in rat placenta and duodenum. Endocrinology. 119:176-184.
17. Dupret, J.M., F. L'Horset, C. Perret, J.F. Bernaudin, and M. Thomasset. 1992. Calbindin-D9K gene expression in the lung of the rat. Absence of regulation by 1,25-dihydroxyvitamin D3 and estrogen. Endocrinology. 131:2643-2648.
18. Delorme, A.C., J.L. Danan, M.G. Acker, M.A. Ripoche, and H. Mathieu. 1983. In rat uterus 17β-estradiol stimulates a calcium-binding protein similar to the duodenal vitamin D-dependent calcium-binding protein. Endocrinology. 113:1340-1347.
19. Bruns, M.E., J.G. Overpeck, G.C. Smith, G.N. Hirsch, S.E. Mills, and D.E. Bruns. 1988. Vitamin D-dependent calcium binding protein in rat uterus: differential effects of estrogen, tamoxifen, progesterone, and pregnancy on accumulation and cellular localization. Endocrinology. 122:2371-2378.
20. L'Horset, F., C. Perret, A. Bréhier, and M. Thomasset. 1990. 17β-estradiol stimulates the calbindin-D9K (CaBP9K) gene expression at the transcriptional and post-transcriptional levels in the rat uterus. Endocrinology. 127: 2891-2897.
21. L'Horset, F., C. Blin, A. Brehier, M. Thomasset, and C. Perret. 1993. Estrogen-induced calbindin-D9k gene expression in the rat uterus during the estrous cycle: late antagonistic effect of progesterone. Endocrinology. 132:489-495.
22. Schreiner, D.S., V. Jande, C.O. Parkes, D.E.M. Lawson, and M. Thomasset. 1983. Immunocytochemical demonstration of two vitamin D-dependent calcium-binding proteins in mammalian. Acta Anat. 117:1-14.
23. Li, H., and S. Christakos. 1991. Differential regulation by 1,25-dihydroxyvitamin D3 of Calbindin-D9K and Calbindin-D28K gene expression in mouse kidney. Endocrinology. 128:2844-2852.
24. Romagnolo, B., F. Cluzeaud, M. Lambert, S. Colnot, A. Porteu, T. Molina, M. Thomasset, A. Vandewalle, A. Kahn, and C. Perret. 1996. Tissue-specific and hormonal regulation of Calbindin-D9K fusion genes in transgenic mice. J. Biol. Chem. In press.
25. Cuif, M.H., M. Cognet, D. Boquet, G. Tremp, A. Kahn, and S. Vaulont. 1992. Elements responsible for hormonal control and tissue specificity of L-type pyruvate kinase gene expression in transgenic mice. Mol. Cell. Biol. 12: 4852-4861.
26. Chomczynski, P., and M. Sacchi. 1987. Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal. Biochem. 162:156-159.
27. L'Horset, F., C. Blin, S. Colnot, M. Lambert, M. Thomasset, and C. Perret. 1994. Calbindin-D9K gene expression in the uterus: study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element. Endocrinology. 134:11-18.
28. Cross, M., and T.M. Dexter. 1991. Growth factors in development, transformation, and tumorigenesis. Cell. 64:271-280.
29. Clarke, E., T. Skaar, K. Baumann, F. Leonessa, M. James, J. Lippman, E.W. Thompson, C. Farter, and N. Brunner. 1994. Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res. Treat. 31:237-248.
30. Pietras, R.J., J. Arboleda, D.M. Reese, N. Wongvipat, M.D. Pegram, L. Ramos, C.M. Gorman, M.G. Parker, M.X. Sliwkowski, and D.J. Slamon. 1995. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene. 10:2435-2446.
31. Kato, S., H. Endoh, Y. Masuhiro, T. Kitamoto, S. Ushiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, et al. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science (Wash. DC). 270:1491-1494.
32. Blin, C., F. L'Horset, B. Romagnolo, S. Colnot, M. Lambert, M. Thomasset, A. Kahn, A. Vandewalle, and C. Perret. 1996. Functional and growth properties of a myometrial cell line derived from transgenic mice: effects of estradiol and antiestrogens. Endocrinology. 137:2246-2253.]
33. Fanning, E. 1992. Structure and function of simian virus 40 large tumor antigen. Annu. Rev. Biochem. 61:55-85.
34. Andreassen, A., E. Oyjord, E. Hovig, R. Holm, V.A. Florenes, J.M. Nesland, O. Myklebost, J. Hoie, A.L. Bruland, and O. Fodstadt. 1993. p53 abnormalities in different subtypes of human sarcomas. Cancer Res. 53:468-471.
35. Friend, S.H., J.M. Horowitz, M.R. Gerber, X.F. Wang, E. Bogenmann, F. Li, and R.A. Weinberg. 1987. Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc. Natl. Acad. Sci. USA. 84:9059-9063.
36. Williams, B.O., L. Remington, D.M. Albert, S. Mukai, T.R. Bronson, and T. Jacks. 1994. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat. Genet. 7:480-484.
37. Fotidou, S.K., A.J. Tserkezoglou, H. Mahera, A.E. Konstandinidou, N.J. Agnantis, N. Pandis, and G. Bardi. 1992. Chromosome aberrations and expression of ras and myc oncogenes in leiomyomas and a leiomyosarcoma of the uterus. Eur. J. Gynaecol. Oncol. 13:340-345.
38. Leach, F.S., T. Tokino, P. Meltzer, M. Burrell, J.D. Oliner, S. Smith, D.E. Hill, D. Sidransky, K.W. Kinzler, and B. Volgestein. 1993. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53:2231-2234.
39. Olinern, J.D., K.W. Kinzler, P.S. Meltzer, D.L. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (Lond.). 358:80-83.